UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000008292 |
|---|---|
| Receipt number | R000009774 |
| Scientific Title | A phase II study of irinotecan + trastuzumab therapy as a second-line chemotherapy for unresectable advanced or recurrent gastric cancer with HER2 overexpression |
| Date of disclosure of the study information | 2012/06/29 |
| Last modified on | 2018/07/04 18:15:50 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2012/06/29 05:36:38 | ||
| 2 | Update | 2012/08/20 15:38:24 | Recruitment status Anticipated trial start date |
|
| 3 | Update | 2018/01/02 11:40:17 | TEL Last name of contact person Last name of contact person TEL Name of primary person or sponsor Organization |
|
| 4 | Update | 2018/07/04 18:15:50 | Recruitment status |
